Friend R, Bhutani M, Voorhees PM, & Usmani SZ. (2017). Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma. Dove Medical Press.
Chicago Style (17th ed.) CitationFriend R, Bhutani M, Voorhees PM, and Usmani SZ. Clinical Potential of SLAMF7 Antibodies – Focus on Elotuzumab in Multiple Myeloma. Dove Medical Press, 2017.
MLA (9th ed.) CitationFriend R, et al. Clinical Potential of SLAMF7 Antibodies – Focus on Elotuzumab in Multiple Myeloma. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.